Pharmaceutical

The global pharmaceutical industry is undergoing a consolidation phase in order to combat price pressure, competition and patent cliffs. Innovation is of vital importance for steady growth of pharmaceutical companies. Pharmaceutical companies have been mainly dependent on a few blockbuster molecules. However,with rapid decline in research and development (R&D) productivity and non-conducive regulatory environment, companies need to find different avenues of growth. The patent expiry of blockbuster drugs is expected to pave way for generics. Due to difference in genetic composition of varied individuals, innovation is becoming more complex.This is influencing players offering complementary products and services to collaborate for new product development.

There are four major factors that are impacting the value creation in pharmaceutical industry:

  • Market
    • Stress from patent expiries, niche marketing, and patient-centricity is challenging the growth plans of pharmaceutical companies. Moreover, in emerging markets, companies face strong competition from local players,who sell product at a much lower cost. To counter the same global companies need to significantly reduce their profit margins.
  • Technology
    • Rapid integration of healthcare and information technology is posing threat for current blockbuster drugs
    • Products based on new technologies offer superior properties and are more efficient as compared to existing products in the market
  • Regulation
    • There is constant price pressure from governments to meet demands of growing number of patients
    • Emerging markets have regulatory uncertainty, where decisions are made to protect the interests of the general population
    • Moreover, governments, especially in emerging economies are encouraging pharmaceutical companies to focus on preventive measures for diseases, which involves major investments
  • Innovation
    • Need for innovative products or therapies is rising constantly due to rising pressure of patent-cliff coupled with reducing profit margins
    • Identification of new bacterial and viral strains is driving the need for novel drugs

Demand for personalized medicines is increasing in order to ensure effective treatment of various diseases

Investments in R&D for oncology and NCDs are increasing globally in order to provide cost-effective solutions available to ailing patients.

Market Challenges

The industry is facing certain challenges such as patent cliff, cost pressure and regulatory uncertainties across the globe. This is hindering market growth to a certain extent. Moreover, regulatory authorities are becoming more stringent with the drug approval process. However, with respect to drugs for rare diseases, the FDA has offered a fast-track approval process. Moreover, demand for cost-effective treatment for chronic and non-communicable diseases such as diabetes, hypertension, thyroid disorder, obesity, and cancer is increasing. However, there is a dearth of strong products in the pipeline that offer better treatment option with fewer side effects. The fear of side effects and long-term treatment costs is encouraging patients to shift to alternative therapies.

Combating Challenges

Market players need to combat these challenges and keep their pace with the industry to sustain their market share. Mergers, acquisitions, and divestitures of products, companies or business division is a rapidly emerging trend in the market to combat prevalent challenges in the market.Companies are more focused in terms of therapy areas and hence, are divesting less focused therapy businesses. A good example is the swap deal between GSK and Novartis in 2015.

Moreover, pharmaceutical companies are investing in consumer health products,with increasing consumer’s health awareness and emerging trend of self-medication. These trends are encouraging pharmaceutical companies to enter the OTC market and leverage their brand equity among the doctors, chemists and consumers. Companies such as GlaxoSmithKline, Cipla, Pfizer, Merck, Sun Pharma, and Abbott have a focused division or subsidiary for consumer healthcare products and markets.

Moreover, to combat increasing cost pressure, companies are evolving their distribution channel. Establishing facilities or presence through collaboration in regional markets has helped companies meet local demand with reduced costs and delivery time. Emergence of e-pharmacy has resulted in creation of a separate team in the organization to service consumers ordering medicines online. Moreover, companies are connecting with consumers through social media, which helps improve brand visibility. The distribution channel has thus evolved significantly from the decade old channel consisting of only wholesalers and physical retail shops.

Patient-centricity

Patients are increasingly becoming well informed and organized, sometimes demanding for a particular product from prescribers. Therefore, companies need to be more patient-centric in their approach and provide quality care to consumers. Pharmaceutical companies are focusing on established direct to consumer distribution channels and establishing a more strong relationship with them. Moreover, companies are creating a good purchase experience for consumers through different offerings such as post-purchase medical services, engaging the patient through social media and events, and providing regular product alerts and refilling services.

Growth in Emerging Economies

The pharmaceutical industry is rapidly expanding in emerging economies such as Asia Pacific, Africa, and Latin America. These regions possess immense potential for growth of pharmaceutical companies, owing to inadequate access to medicines, growing population and increasing incidence of non-communicable diseases (NCDs). Besides, demand for contract research and manufacturing is also high in these regions. China and India are the largest emerging markets for CRO and CMO. Companies are highly dependent on China for API supply owing to low purchase cost. Overdependence on a single country can pose a challenge for the pharmaceuticals sector in the near future. Therefore, other emerging countries such as India, Brazil and South Africa are encouraging investments in their country. Besides, global companies are establishing their facilities in Asia Pacific, Middle East and Latin America regions to enable close monitoring and servicing of lucrative regional markets.

Conclusion

Pharmaceutical companies need to focus on an integrated, patient-centric, value-driven approach along with technology integration and strategic partnerships in order to capitalize on lucrative growth opportunities in the market. Major global players in the market include Pfizer Inc., Merck & Co., Inc., Bayer AG, GlaxoSmithKline plc., Sanofi, F. Hoffmann-La Roche AG, AstraZeneca plc. and Novartis AG.

There is a paradigm shift in process in the global pharmaceutical industry from product to a ‘Prodice’ (Product and Service) model, to offer affordable, accessible and quality care to patients.

Insights are not available.
Coherent Market Insights
Angiosarcomas Treatment Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025

To Be Published : Mar 2018

Sarcoma is a group of soft tissue tumors and a rare and clinically variable type of cancer that originates due to the transformation of mesenchymal cells. Angiosarcomas mainly occurs in the breast, bone, skin, soft tissues, and spleen. It grows in the cells of blood v

Coherent Market Insights
Nanomedicines Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025

To Be Published : Mar 2018

Medical application of nanotechnology is referred as nanomedicine. Potential applications include in biological devices, nanomaterials, nanoelectronic biosensors, molecular nanotechnology including biological machines. Some of the recent problems for nanomedicines inc

Coherent Market Insights
Opioid Induced Side Effects Treatment Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025

To Be Published : Mar 2018

Opioids are the class of drug that include strong pain relievers and illegal drugs such as heroin and illicit pain relievers for example hydrocodone, oxycodone, morphine and fentanyl. Also they are available legally on prescription. These drugs interact with opioid re

Coherent Market Insights
Ioversol Market - Global Industry Insights, Size, Share, Trends, Outlook, and Opportunity Analysis, 2017–2025

To Be Published : Mar 2018

Ioversol is a white to off-white crystalline powder having a crystalline sulfide-like odor. It is a non-ionic radiological contrast agent that is included in a group of drugs known as radiopaque contrast agents. It contains iodine, a substance that has the ability to

Coherent Market Insights
Polio Vaccines Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025

To Be Published : Mar 2018

Poliomyelitis is highly infectious disease caused by poliovirus. It is also known as polio or infantile paralysis. The virus belongs to genus Enterovirus which is a type of single-stranded RNA virus. There are three serotypes of poliovirus: P1,

Coherent Market Insights
Breast Cancer Therapeutics Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016–2024

To Be Published : Mar 2018

Cancer is essentially the uncontrolled growth of certain cells in the body that crowd out normal cells over time. When cells in the breast begin to grow out of control it may lead to breast cancer. These cells generally form a tumor that can felt as a lump, which can

Coherent Market Insights
Pyrogen Testing Market — Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016–2024

To Be Published : Mar 2018

Pyrogen testing is used to measure the presence of pyrogen in an organism that causes fever. Pyrogens are substances that can cause fever and these substances can be found in lipopolysaccharides and lepoteichoic acid. Pyrogen contamination can be found in pharmaceutic

Coherent Market Insights
Non-Small Cell Lung Cancer Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016–2024

To Be Published : Mar 2018

Cancer is the disease in which cell grows abnormally and may cause a tumor. In lung cancer, the cells of lungs starts to grow in uncontrolled manner later form a tumor and can be spread into other body parts. Small cell lung cancer and non-small cell lung cancer are t

Coherent Market Insights
Bladder Cancer Therapeutics Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016–2024

To Be Published : Mar 2018

As per stats released by the World Cancer Research Fund International, around 430,000 new cases of bladder cancer were diagnosed in 2012, with bladder cancer being the ninth-most common cancer. The bladder holds urine before it leaves the body during urination. The di

Coherent Market Insights
Ulcerative Colitis Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016–2024

To Be Published : Mar 2018

Ulcerative colitis is the most common type of inflammatory bowel disease that affects the colon (lining of the large intestine) and rectum. The inflammation produces tiny sores called ulcers. These disease can affect people of any age, though prevalence is especially

Coherent Market Insights
Anti-Fungal Drugs Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016–2024

To Be Published : Mar 2018

As the name suggests, anti-fungal drugs are used to treat fungal infections. Common fungal infections such as fungal nail infection, vaginal infection, and ringworm usually occur on the external surface of the body, while certain fungal invasive infections occur insid

Coherent Market Insights
Cystic Fibrosis Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016–2024

To Be Published : Mar 2018

Cystic fibrosis (CF) is a genetic disorder that usually affects the lungs and may also affect the pancreas, kidneys, liver, and intestine. Long-term repercussions including difficulty in breathing and coughing as a result of recurrent lung infections can be seen in CF

Coherent Market Insights
Protein A Resin Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016–2024

To Be Published : Mar 2018

Protein A is a bacterial protein, which has capacity to bind mammalian antibodies of class immunoglobulin G with great affinity. Protein G binds to all subclasses of human immunoglobulin G (IgG) makes it useful for purifying polyclonal or monoclonal IgG antibodies who

Coherent Market Insights
Pet Health Products Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016–2024

To Be Published : Mar 2018

A pet or companion animal is an animal kept primarily for one's company, protection, or entertainment. Popular pets are regularly noted for their attractive appearances and their loyal or playful personalities. While dogs and cats are the most preferred pet animals, p

Coherent Market Insights
Candidiasis Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016–2024

To Be Published : Mar 2018

Candidiasis is a type of infection caused due to candida—an yeast and also classified as fungus, which is present in the human body. It is usually present in places like mouth, belly, and on the skin. The overgrowth of these leads to an infection. This dormant y

Coherent Market Insights
Cosmeceuticals Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016–2024

To Be Published : Mar 2018

Cosmetics and pharmaceuticals together make cosmeceuticals. A cosmeceutical has the active potential ingredient to bring about visible changes to the skin, and these changes are backed by clinical indication. Cosmeceutical products are marketed as cosmetics, though th

Coherent Market Insights
Tardive Dyskinesia Drugs Market — Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016–2024

To Be Published : Mar 2018

Tardive dyskinesia (TD) is a form of dyskinesia that is difficult to treat. It is a nerve disorder characterized by involuntary movements such as jaw, lips, and tongue, considered as grimacing, sticking the tongue out, and lip smacking. Some other symptoms are an

Coherent Market Insights
Global Nanoparticles Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016–2024

To Be Published : Mar 2018

Particles between 1 and 100 nanometers (nm) in size known as nanoparticles. An individual nanoparticle molecule behaves as a complete unit in terms of its property and transportation. Rapidly increasing public awareness for nanotechnology and introduction of new techn

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

Coherent Market Insights Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.